TY - JOUR
T1 - Comprehensive Review
T2 - Unveiling the Pro-Oncogenic Roles of IL-1ß and PD-1/PD-L1 in NSCLC Development and Targeting Their Pathways for Clinical Management
AU - Castillo, Dani Ran
AU - Jeon, Won Jin
AU - Park, Daniel
AU - Pham, Bryan
AU - Yang, Chieh
AU - Joung, Bowon
AU - Moon, Jin Hyun
AU - Lee, Jae
AU - Chong, Esther G.
AU - Park, Kiwon
AU - Reeves, Mark E.
AU - Duerksen-Hughes, Penelope
AU - Mirshahidi, Hamid R.
AU - Mirshahidi, Saied
N1 - Publisher Copyright:
© 2023 by the authors.
PY - 2023/7
Y1 - 2023/7
KW - immune-checkpoint inhibitors (ICIs)
KW - interleukin-1 beta (IL-1β)
KW - non-small cell lung cancer (NSCLC)
KW - programmed death ligand 1 (PD-L1)
KW - therapeutic resistance
UR - http://www.scopus.com/inward/record.url?scp=85165993034&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85165993034&partnerID=8YFLogxK
U2 - 10.3390/ijms241411547
DO - 10.3390/ijms241411547
M3 - Review article
C2 - 37511306
AN - SCOPUS:85165993034
SN - 1661-6596
VL - 24
JO - International Journal of Molecular Sciences
JF - International Journal of Molecular Sciences
IS - 14
M1 - 11547
ER -